Abstract
We herein describe two patients with Brugada syndrome in whom J-waves were successfully modified by drugs. Case 1 was a 54-year-old man who presented with repeated ventricular fibrillations (VF) and J-point elevation in the right precordial and lateral leads. After administration of cilostazol (200 mg/d), J-waves disappeared and coved-type ST-segment elevation changed to a saddleback-type for 25 months. Case 2 was a 31-year-old man who presented with a VF storm and J-point elevation in the lateral leads. After administration of quinidine (300 mg/d), J-waves and coved-type ST-segment elevation disappeared for 20 months. Jwave disappearance and coved-type ST-segment elevation were followed by VF suppression, probably due to transient outward potassium current (I to) suppression. © 2014 The Japanese Society of Internal Medicine.
Author supplied keywords
Cite
CITATION STYLE
Hasegawa, K., Ashihara, T., Kimura, H., Jo, H., Itoh, H., Yamamoto, T., … Horie, M. (2014). Long-term pharmacological therapy of Brugada syndrome: Is J-wave attenuation a marker of drug efficacy? Internal Medicine, 53(14), 1523–1526. https://doi.org/10.2169/internalmedicine.53.1829
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.